AI-Driven CAD Risk Assessment and Triage with CardioClin™

HeartForce’s CardioClin™ enables fast, non-invasive CAD risk assessment, right at the point of care.

CardioClin CAD risk screening Device Model Front

Fast.
Non-invasive.
Accurate.

60 secrecording time.

What Is the CardioClin™ Product?

The CardioClin™ is a compact, cost-effective, and AI-powered device that measures the mechanical activity of the heart to assess the risk of CAD. It provides a quick and easy option compared to traditional health screening tests. Suitable for primary care, pharmacies, occupational & institutional medicine settings, and cardiology departments.

CardioClin™ vs. Traditional CAD Tests

Swipe to see the full table →

Feature
CardioClin™
Stress ECG
Calcium Score (CACS)
Under 5 min Test
Asymptomatic Testing
Comfort
High Rule-Out Confidence
No Hardware Cost
Under $100 per Test
Follow-up Efficiency
Nurse and GP Usability
Non-Invasive
Portability

Why Choose CardioClin™?

  • Only 60 seconds of data capture, enabling immediate triage.
  • No needles, radiation, or discomfort.
  • Suitable for adults with symptoms or an elevated likelihood of CAD.
  • Outperforms conventional screening tools like stress ECG and calcium scoring in identifying and ruling out CAD risk.
Close-up of HeartForce CardioClin sensor attached to a patient’s chest

Accurate, Affordable, and Fast

See CardioClin™ in Action

Product Specifications

CardioClinc Device Video

Ready to Transform Your Approach to CAD Screening?

HeartForce’s CardioClin™ empowers clinicians, supports patients, and streamlines healthcare systems, one test at a time.

CardioClin™ Instructions For Use – Soon available

PDF · Instructions for Use, CardioClin™ System CC-1000

You are leaving the US website

You are leaving the US version of the HeartForce website and entering our global website.

Product availability, regulatory status, risk categorisation, and performance claims may differ between regions and may not apply to the United States.

CardioClin™ is not cleared or approved by the U.S. Food and Drug Administration (FDA).

Please return to the US website for information applicable to the United States.